Show results for
Refine by
Clinical Screening Trial Equipment Supplied In Canada
26 equipment items found
by:saNOtize Research and Development Corp. based inVancouver, CANADA
VirX and enovid are identical formulations based on our NORS (Nitric Oxide Releasing Solution) platform technology. They have the same active ingredients and mechanisms of action as those nasal therapeutics used in our clinical ...
by:saNOtize Research and Development Corp. based inVancouver, CANADA
VirX and enovid are identical formulations based on our NORS (Nitric Oxide Releasing Solution) platform technology. They have the same active ingredients and mechanisms of action as those nasal therapeutics used in our clinical ...
by:Forest Devices based inPittsburgh, PENNSYLVANIA (USA)
Forest Devices has developed a disruptive technology: the first objective, electronically-determined test for stroke for use by EMS. shown an increase in diagnostic accuracy of 92% in pilot clinical trials of nearly 300 people expected to reduce — and possibly eliminate in some cases — disabilities, rehabilitation costs and even death from stroke expected to reduce or avoid hospital ...
Manufactured by:Triple Hair Inc. based inDieppe, NEW BRUNSWICK (CANADA)
This innovative triple combination therapy promotes hair regrowth in men with androgenic alopecia. Its exclusive combination of molecules acts at various stages of the hair growth cycle to stop hair loss and stimulate regrowth, while also making hair thicker and darker. The effectiveness of this revolutionary solution was proven in the first two phases of clinical trials, where participants all ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 is a HER2-targeted antibody drug conjugate (ADC) developed using Zymeworks’ proprietary Azymetric™ and ZymeLink™ platforms. ZW49 is currently being evaluated in a Phase 1 clinical trial as a treatment for patients with locally advanced or metastatic HER2-expressing cancers that have progressed following treatment with existing approved therapies, including HER2-targeted ...
by:Enveric Biosciences, Inc. based inNaples, FLORIDA (USA)
Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies. Preclinical data suggests combination therapies may improve the activity of certain chemotherapies or cancer immunotherapies, potentially enabling more potent or longer-lasting therapeutic effects. In addition, combination therapies may allow for the same or greater therapeutic effect ...
Manufactured by:Spectral Medical Inc. based inToronto, ONTARIO (CANADA)
PMX is a Polymyxin B extracorporeal direct hemoperfusion adsorption column which is highly effective in removing endotoxin in the bloodstream. Clinically available since 1995*. As of 2019, more than 200,000 treatments performed . Reproducible clinical benefits. As of 2019, more than 200 scientific papers and peer reviewed articles ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks’ lead product candidate, zanidatamab, is a HER2-targeted bispecific antibody developed using Zymeworks proprietary Azymetric platform. Zanidatamab is currently being evaluated in global Phase 1, Phase 2 and pivotal clinical trials as a best-in-class treatment for patients with HER2-expressing cancers, including biliary tract, gastroesophageal adenocarcinomas, breast, and other ...
Manufactured by:CanaQuest Medical Corp. based inMississauga, ONTARIO (CANADA)
What are clinical trials? Clinical trials are a way to test new methods of diagnosing, treating, or preventing health conditions. The goal is to determine whether something is both safe and effective. A variety of things are evaluated through clinical trials, including: Effectiveness of medications, minimum and ultimate dose, medication combinations. Based on positive results from the preclinical ...
Manufactured by:Emergent BioSolutions Inc. based inGaithersburg, MARYLAND (USA)
Raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs. Raxibacumab is also indicated for prophylaxis of inhalational anthrax when alternative therapies are not available or are not ...
Distributed by:Green Cross Medico Ltd based inHamilton, ONTARIO (CANADA)
Airglove is a worldwide patented air warming system developed to enable venipuncture and difficult intravenous access in a patients arm for the delivery of intravenous drugs. It gently heats the patients arm up as it forces warm air through a double walled polythene glove. ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCS-01 is a proprietary autologous cell therapy being developed to rejuvenate aging or UV-damaged skin.* *This product is currently in clinical testing and not yet commercially available. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
Manufactured by:Hemostemix Inc. based inCalgary, ALBERTA (CANADA)
Hemostemix is currently conducting a randomized, double-blind, placebo-controlled Phase 2 clinical trial for patients with critical limb ischemia at sites in the Canada and United ...
Manufactured by:Bionic Power Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
Designed as a gait rehabilitation device, the Agilik smart orthosis moves with the wearer, providing dynamic knee assistance and resistance, when needed during a patient’s gait. This helps patients with crouch gait stand more upright, gain muscle strength, and learn to walk more efficiently and with more independence. The Agilik is designed to be light, easy to doff and don, and ...
Manufactured by:Bedfont Scientific Limited based inKent, UNITED KINGDOM
The Micro+™ Smokerlyzer CO device is the new and improved version of the revolutionary Micro+™ Smokerlyzer. The Micro+™ Smokerlyzer is a longstanding benchmark device used in clinical trials and research and is the one CO monitor for all your testing ...
Manufactured by:BioMark Diagnostics Inc. based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark has invested in and developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early stage diagnosis of lung ...
Manufactured by:RepliCel Life Sciences based inVancouver, BRITISH COLUMBIA (CANADA)
RCT-01 is a proprietary autologous cell therapy being developed to treat chronically damaged tendons. * *This product is currently in clinical testing and not yet commercially available. RCT-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells - a type of fibroblast cell - isolated from the hair follicle to repair and regenerate tissue. Though several cell types are ...
Manufactured by:CanaQuest Medical Corp. based inMississauga, ONTARIO (CANADA)
Clinical testing on humans can only begin after a pre-clinical phase, involving laboratory studies (in vitro) and tests on animals, which has shown that the experimental drug is considered safe and effective. However, no animal is sufficiently similar to humans (even genetically modified ones) to make human testing unnecessary. For this reason, the experimental drug must also be tested on humans. ...
Manufactured by:Renishaw plc based inGloucestershire, UNITED KINGDOM
Novel chronic and acute catheter systems for direct delivery of therapeutics to the ...
Manufactured by:InMed Pharmaceuticals Inc. based inVancouver, BRITISH COLUMBIA (CANADA)
INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic ...